SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002456
Filing Date
2021-10-28
Accepted
2021-10-28 16:03:11
Documents
69
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-20210930.htm   iXBRL 10-Q 2152217
2 EX-10.1 aldx-ex10_1.htm EX-10.1 35870
3 EX-31.1 aldx-ex31_1.htm EX-31.1 16877
4 EX-31.2 aldx-ex31_2.htm EX-31.2 17215
5 EX-32.1 aldx-ex32_1.htm EX-32.1 14447
  Complete submission text file 0000950170-21-002456.txt   6611657

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aldx-20210930_cal.xml EX-101.CAL 41892
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aldx-20210930_def.xml EX-101.DEF 129863
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aldx-20210930.xsd EX-101.SCH 43359
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aldx-20210930_pre.xml EX-101.PRE 251267
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aldx-20210930_lab.xml EX-101.LAB 340976
11 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20210930_htm.xml XML 1029876
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 211358192
SIC: 2834 Pharmaceutical Preparations